To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SMUG1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
276 supporting clones for gene SMUG1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BP253763 Kidney .a 1 to 574 9 to 582       582/582
(100 %)
0 diff
(100 %id)
DA784961 brain .a 1 to 563 10 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA925331 small intestine .a 1 to 582 10 to 591   tiling clone, capped   590/590
(100 %)
0 diff
(100 %id)
DA741011   .a 1 to 545 9 to 554   capped   553/554
(99 %)
2 diff
(99.7 %id)
DA902749   .a 1 to 539 9 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA948858 Spleen .a 1 to 511 9 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BQ420298 epithelioid carcinoma, Pancreas .a 1 to 469 2 to 474       474/804
(58 %)
6 diff
(99.3 %id)
BG489892 large cell carcinoma, lung .a 2 to 859 1 to 855 G75V R140D F141S W142G G143A ...     855/914
(93 %)
30 diff
(96.8 %id)
BY799838 eye .a 4 to 601 1 to 598       598/598
(100 %)
0 diff
(100 %id)
CX166765 human embryonic stem cells differentiated toan early endodermal cell type .a 6 to 712 1 to 707       707/707
(100 %)
0 diff
(100 %id)
Z42793 brain, total brain .a 7 to 285 1 to 279       279/279
(100 %)
0 diff
(100 %id)
BQ959462 leiomyosarcoma, uterus .a 7 to 933 1 to 937 R208P R243V N244T P245H Q246K ...     937/940
(99 %)
33 diff
(96.5 %id)
CX787223 human embryonic stem cells .a 7 to 711 1 to 705       705/705
(100 %)
0 diff
(100 %id)
CD245413 White Matter .a 9 to 831 1 to 830       830/877
(94 %)
13 diff
(98.6 %id)
BE280767 choriocarcinoma, placenta .a 10 to 456 1 to 447       447/447
(100 %)
0 diff
(100 %id)
CR591967 Placenta Cot 25-normalized .a 13 to 1443 1 to 1431 exact tiling clone,   1431/1431
(100 %)
0 diff
(100 %id)
AK290274 colon .a 17 to 1100 37 to 1120 exact     1120/1120
(100 %)
2 diff
(99.9 %id)
DA430734 colon .a 17 to 548 37 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB468649 hippocampus .a 17 to 131 38 to 152       152/152
(100 %)
7 diff
(95.4 %id)
BG706635 brain, hypothalamus .a 17 to 742 48 to 774       774/774
(100 %)
4 diff
(99.5 %id)
BI770782 pooled lung and spleen .a 17 to 873 34 to 889 C159L V161C H162P N163Q L164S ...     889/932
(95 %)
31 diff
(96.7 %id)
BI770712 pooled lung and spleen .a 17 to 635 34 to 658       658/683
(96 %)
21 diff
(97.0 %id)
TI_57184076   .a 17 to 635 64 to 688       663/713
(92 %)
26 diff
(96.4 %id)
TI_57184146   .a 17 to 873 63 to 918 C159L V161C H162P N163Q L164S ...     894/961
(93 %)
38 diff
(96.1 %id)
DA783952 brain .a 17 to 554 36 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA809711 brain .a 17 to 502 35 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
DN993458 brain, whole brain .a 17 to 664 45 to 693       693/693
(100 %)
7 diff
(99.0 %id)
BU183280 melanotic melanoma, skin .a 794 to 1585 1 to 803   AAA   803/926
(86 %)
16 diff
(98.3 %id)
DN917663   .a 1061 to 1616 1 to 555       555/574
(96 %)
6 diff
(99.0 %id)
DN917664   .a 1155 to 1615 460 to 1       460/460
(100 %)
12 diff
(97.4 %id)
Z38938 brain, total brain .a 1168 to 1472 305 to 1       305/305
(100 %)
0 diff
(100 %id)
DA084570 cerebellum .a 1219 to 1689 2 to 472   capped   471/471
(100 %)
1 diff
(99.8 %id)
AI380986 B-cell, chronic lymphotic leukemia .a 1426 to 1804 379 to 1   tiling clone,   379/379
(100 %)
0 diff
(100 %id)
AA247823   .a 1508 to 1666 1 to 159       159/159
(100 %)
0 diff
(100 %id)
AL135633 melanoma (MeWo cell line) .a 1631 to 2292 1 to 660       660/660
(100 %)
4 diff
(99.4 %id)
BG179161 adenocarcinoma, cell line, Prostate .a 1743 to 2467 1 to 725       725/726
(99 %)
27 diff
(96.3 %id)
BF032930 adenocarcinoma, ovary .a 1751 to 2460 1 to 727       727/806
(90 %)
39 diff
(95.2 %id)
BU957376 adenocarcinoma, cell line, breast .a 1768 to 2488 1 to 725   tiling clone,   725/907
(79 %)
12 diff
(98.7 %id)
BX366280 Neuroblastoma Cot 25-normalized .a 2079 to 2542 464 to 1       464/481
(96 %)
2 diff
(99.6 %id)
BX366281 Neuroblastoma Cot 25-normalized .a 2079 to 2589 18 to 528       511/528
(96 %)
6 diff
(98.9 %id)
BX375388 Neuroblastoma Cot 25-normalized .a 2079 to 2589 18 to 529       512/529
(96 %)
6 diff
(98.9 %id)
BI334904 cervical carcinoma cell line, cervix .a 2079 to 2782 1 to 708       708/708
(100 %)
8 diff
(98.9 %id)
BI333703 cervical carcinoma cell line, cervix .a 2079 to 2859 1 to 771   tiling clone,   771/771
(100 %)
14 diff
(98.2 %id)
AI814126 normal prostate, Prostate .a 2103 to 2589 489 to 3       487/489
(99 %)
0 diff
(100 %id)
AA228072 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2215 to 2566 1 to 349       349/349
(100 %)
4 diff
(98.9 %id)
AI002776   .a 2364 to 2585 241 to 20   AAA   222/222
(100 %)
1 diff
(99.6 %id)
GD146341   .a 2485 to 2585 1 to 101   AAA   101/101
(100 %)
3 diff
(97.1 %id)
BI253529 cervical carcinoma cell line, cervix .a 2666 to 3216 35 to 582       548/582
(94 %)
6 diff
(99.0 %id)
BE048761 Kidney .a 2667 to 3130 466 to 3   tiling clone,   464/466
(99 %)
0 diff
(100 %id)
AW450546   .a 2908 to 3379 489 to 18   tiling clone, AAA   472/472
(100 %)
1 diff
(99.8 %id)
AI356760 brain, glioblastoma (pooled) .a 2917 to 3379 464 to 1       464/464
(100 %)
6 diff
(98.8 %id)
BG334846 melanotic melanoma, skin .b -9 to 699 1 to 733       733/1082
(67 %)
49 diff
(95.5 %id)
DA910831   .b 1 to 537 10 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA004760   .b 1 to 563 9 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AK001235   .b 1 to 1563 8 to 1570 exact tiling clone, available from FLJ,   1570/1570
(100 %)
0 diff
(100 %id)
DA455590 tongue, tumor tissue .b 1 to 536 9 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
NM_014311.1   .b 1 to 1563 8 to 1570 exact RefSeq,   1570/1570
(100 %)
0 diff
(100 %id)
AU124270   .b 1 to 773 8 to 785   capped   784/784
(100 %)
11 diff
(98.6 %id)
BP212020 cerebrum .b 1 to 581 3 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BE612990 adenocarcinoma, ovary .b 6 to 654 65 to 709       645/668
(96 %)
11 diff
(98.4 %id)
BI115721 lung, small cell carcinoma .b 10 to 771 1 to 759       759/759
(100 %)
6 diff
(99.3 %id)
BE277425 melanotic melanoma, skin .b 11 to 617 1 to 607       607/607
(100 %)
0 diff
(100 %id)
BE277346 melanotic melanoma, skin .b 11 to 669 1 to 653       653/653
(100 %)
9 diff
(98.7 %id)
BX457976 neuroblastoma .b 14 to 968 1 to 952 F144X E235G G236R L237A L238P ...     952/1000
(95 %)
7 diff
(99.3 %id)
CA488132   .b 17 to 882 1 to 880       880/912
(96 %)
23 diff
(97.5 %id)
TI_57217491   .b 17 to 872 70 to 927       861/930
(92 %)
14 diff
(98.5 %id)
TI_57199835   .b 17 to 857 43 to 889       850/890
(95 %)
21 diff
(97.7 %id)
CA406632 adipose .b 18 to 580 1 to 563       563/563
(100 %)
3 diff
(99.5 %id)
BE885112 leiomyosarcoma, uterus .b 18 to 707 1 to 691       691/1070
(64 %)
20 diff
(98.2 %id)
BE256109 eye, retinoblastoma .b 36 to 551 1 to 516       516/516
(100 %)
0 diff
(100 %id)
BE744735 adenocarcinoma cell line, ovary .b 37 to 782 1 to 741       741/774
(95 %)
11 diff
(98.6 %id)
BQ439210 epithelioid carcinoma, Pancreas .b 50 to 871 1 to 833       833/887
(93 %)
16 diff
(98.2 %id)
BQ230713 leiomyosarcoma, uterus .b 80 to 1077 1 to 1000 N244T P245H Q246R A247P A255G ...     1000/1004
(99 %)
21 diff
(98.0 %id)
TI_43963334   .b 95 to 866 36 to 805   fully sequenced,   775/810
(95 %)
7 diff
(99.2 %id)
BI520134 brain, medulla .b 96 to 898 1 to 801   fully sequenced,   801/801
(100 %)
5 diff
(99.4 %id)
R51146 whole brain .b 98 to 581 1 to 489       493/489
(100 %)
16 diff
(96.8 %id)
AL550716.
matches multiple genes
placenta, Placenta Cot 25-normalized .b 100 to 821 1 to 731   fully sequenced, also hits gene kusweyby 731/731
(100 %)
30 diff
(95.9 %id)
AA293550 ovarian tumor, ovary .b 105 to 606 1 to 502       502/502
(100 %)
11 diff
(97.9 %id)
BG290019 bladder, transitional cell papilloma, cell line .b 107 to 610 1 to 512       512/952
(53 %)
19 diff
(98.1 %id)
AF125182 ovary tumor .b 109 to 1563 19 to 1473 exact tiling clone, AAA   1455/1473
(98 %)
8 diff
(99.5 %id)
BE410071 choriocarcinoma, placenta .b 194 to 732 177 to 728       552/889
(62 %)
36 diff
(96.0 %id)
CR609554 Placenta Cot 25-normalized .b 206 to 1546 1 to 1341       1341/1341
(100 %)
0 diff
(100 %id)
AL543196 placenta, Placenta Cot 25-normalized .b 206 to 1142 1 to 934   fully sequenced,   934/934
(100 %)
0 diff
(100 %id)
CN403143 embryonic stem cells, DMSO-treated H9 cellline .b 250 to 972 1 to 725       725/725
(100 %)
2 diff
(99.8 %id)
AA337554 endometrium .b 398 to 646 1 to 249       249/249
(100 %)
0 diff
(100 %id)
AW960789   .b 399 to 781 1 to 383       383/499
(76 %)
15 diff
(97.0 %id)
AL574496.
matches multiple genes
placenta, Placenta Cot 25-normalized .b 791 to 1530 738 to 1   fully sequenced, also hits gene kusweyby 738/738
(100 %)
15 diff
(98.0 %id)
TI_43963335   .b 836 to 1496 683 to 17   fully sequenced,   667/683
(97 %)
12 diff
(98.3 %id)
BI520902 brain, medulla .b 868 to 1496 651 to 17   fully sequenced,   635/651
(97 %)
12 diff
(98.2 %id)
AL569824 placenta, Placenta Cot 25-normalized .b 1112 to 1546 425 to 1   fully sequenced,   425/425
(100 %)
6 diff
(98.6 %id)
AA293551 ovarian tumor, ovary .b 1178 to 1562 386 to 2       385/386
(99 %)
0 diff
(100 %id)
BG033474 breast, mammary adenocarcinoma, cell line .c 1 to 721 1 to 721 G75A K77R E78K V79Y L80S ... tiling clone, AAA   721/721
(100 %)
23 diff
(96.9 %id)
BU190546 melanotic melanoma, cell line, skin .d 1 to 712 1 to 714 exact AAA   714/714
(100 %)
5 diff
(99.3 %id)
BU195802 melanotic melanoma, cell line, skin .d 1 to 711 1 to 711 exact tiling clone, AAA   711/711
(100 %)
0 diff
(100 %id)
BU156849 melanotic melanoma, cell line, skin .d 1 to 711 1 to 714 exact tiling clone, AAA   714/714
(100 %)
3 diff
(99.6 %id)
BU195836 leiomyosarcoma, uterus .d 3 to 696 1 to 694 exact AAA   694/694
(100 %)
3 diff
(99.6 %id)
BQ894691 melanotic melanoma, cell line, skin .d 11 to 580 86 to 658       574/1134
(50 %)
20 diff
(98.3 %id)
W78830 liver and spleen .d 93 to 567 11 to 485       479/485
(98 %)
9 diff
(98.2 %id)
BG696498 skin .d 94 to 665 10 to 583 G75A K77R E78K V79Y L80S ...     577/583
(98 %)
7 diff
(98.8 %id)
R28565 placenta .d 97 to 432 1 to 350   fully sequenced,   348/348
(100 %)
19 diff
(94.6 %id)
CV026675 mixed .d 116 to 648 1 to 533       533/604
(88 %)
0 diff
(100 %id)
TI_1948089275   .d 116 to 649 131 to 664 S155N R165K V166M R169I G172D     534/1090
(48 %)
13 diff
(98.9 %id)
TI_1948089476   .d 116 to 647 133 to 662       530/1040
(50 %)
21 diff
(98.0 %id)
TI_1948089662   .d 116 to 648 132 to 665       534/1069
(49 %)
26 diff
(97.6 %id)
TI_1948089841   .d 116 to 648 138 to 672       535/1083
(49 %)
28 diff
(97.5 %id)
AW409850 muscle, rhabdomyosarcoma .d 147 to 701 581 to 27       555/581
(95 %)
0 diff
(100 %id)
AW083620 colon, moderately differentiated adenocarcinoma .d 170 to 694 531 to 4       528/531
(99 %)
5 diff
(99.1 %id)
AW410643 muscle, rhabdomyosarcoma .d 220 to 697 481 to 4       478/481
(99 %)
0 diff
(100 %id)
AI078315 liver and spleen .d 244 to 697 454 to 1       454/454
(100 %)
0 diff
(100 %id)
AA833766 germinal center B cell .d 256 to 711 472 to 17   AAA   456/456
(100 %)
1 diff
(99.8 %id)
AI074944 senescent fibroblast .d 270 to 697 435 to 7       429/435
(98 %)
2 diff
(99.6 %id)
AI333829 lung .d 286 to 695 410 to 1       410/410
(100 %)
1 diff
(99.8 %id)
AW445111   .d 327 to 699 390 to 18   AAA   373/383
(97 %)
0 diff
(100 %id)
BI335788 skin .d 352 to 697 1 to 346       346/346
(100 %)
1 diff
(99.8 %id)
AV691674 hepatocellular carcinoma .d 379 to 711 1 to 324   AAA   327/324
(100 %)
16 diff
(95.1 %id)
AI684915 pooled .d 400 to 712 329 to 17   AAA   313/321
(97 %)
6 diff
(98.2 %id)
R28360 placenta .d 401 to 697 307 to 1   fully sequenced,   307/307
(100 %)
11 diff
(96.5 %id)
AV692765 hepatocellular carcinoma .d 410 to 711 24 to 319   AAA   296/319
(92 %)
8 diff
(97.5 %id)
AA862712 pooled germ cell tumors .d 417 to 698 291 to 10       282/291
(96 %)
0 diff
(100 %id)
BF054960 pooled .d 456 to 716 268 to 1       268/278
(96 %)
12 diff
(95.7 %id)
W80729 liver and spleen .d 572 to 715 145 to 2       144/155
(92 %)
0 diff
(100 %id)
DA638931 Liver .e 1 to 290 2 to 291   tiling clone, capped   290/290
(100 %)
1 diff
(99.7 %id)
CN481641 eye .e 11 to 367 1 to 357       357/357
(100 %)
4 diff
(98.9 %id)
BG778599 adenocarcinoma, Prostate .e 17 to 707 37 to 729 exact tiling clone, AAA   729/729
(100 %)
4 diff
(99.5 %id)
BG034066 breast, mammary adenocarcinoma, cell line .e 20 to 704 32 to 726 G75A K77R E78K V79Y L80S ... AAA   697/726
(96 %)
22 diff
(97.0 %id)
T31643 colon, embryo .e 20 to 389 1 to 371   tiling clone,   371/371
(100 %)
2 diff
(99.5 %id)
BF945724 nervous_normal .e 30 to 327 306 to 10     Submitted on the opposite strand 297/322
(92 %)
1 diff
(99.7 %id)
CA432229 cell lines, Enchondroma .e 89 to 706 635 to 19 S9P I10S H11M E12S P13L ... tiling clone, AAA   617/617
(100 %)
2 diff
(99.7 %id)
DB062581 testis .f -8 to 538 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
BC105607 Pooled, 40 cell lines .f 1 to 616 9 to 624 exact tiling clone, AAA   624/624
(100 %)
5 diff
(99.2 %id)
BU953422 mixed (pool of 40 RNAs) .f 1 to 614 8 to 626 Q139P K146*     626/725
(86 %)
13 diff
(98.3 %id)
DA835884 placenta .f 1 to 437 9 to 445   capped   444/444
(100 %)
0 diff
(100 %id)
CB163825 Liver .f 7 to 507 1 to 501       501/503
(99 %)
1 diff
(99.9 %id)
CB164306 Liver .f 7 to 581 1 to 575 exact     575/575
(100 %)
0 diff
(100 %id)
CB997012 placenta, pre-eclamptic placenta .f 17 to 618 52 to 654 exact tiling clone, AAA   634/654
(96 %)
7 diff
(99.0 %id)
CB991546 placenta, pre-eclamptic placenta .f 17 to 616 52 to 660 K123X P132A I145N K146*     640/858
(74 %)
26 diff
(97.0 %id)
CB992610 placenta, pre-eclamptic placenta .f 17 to 509 52 to 544       524/557
(94 %)
7 diff
(98.8 %id)
T31349 colon .f 17 to 245 1 to 229       229/229
(100 %)
0 diff
(100 %id)
BM751457 Ascites, stomach .f 85 to 230 1 to 146       146/146
(100 %)
0 diff
(100 %id)
FN126347 breast carcinoma .f 165 to 222 1 to 58       58/62
(93 %)
1 diff
(98.4 %id)
AA507434 breast .f 446 to 617 175 to 4       172/175
(98 %)
0 diff
(100 %id)
EC480604 Prostate .f 464 to 554 1 to 90       90/92
(97 %)
8 diff
(91.4 %id)
AA422055.
matches multiple genes
ovarian tumor, ovary .f 464 to 604 141 to 1     also hits gene CABC1 141/141
(100 %)
1 diff
(99.3 %id)
D19872   .f 503 to 617 1 to 115     Submitted on the opposite strand 115/117
(98 %)
1 diff
(99.2 %id)
DA199774 brain .g 1 to 572 2 to 573   tiling clone, capped   572/572
(100 %)
2 diff
(99.7 %id)
BC088352 Uterus, leiomyosarcoma .g 135 to 921 1 to 787 exact tiling clone, AAA   787/787
(100 %)
1 diff
(99.9 %id)
BQ937959 leiomyosarcoma, uterus .g 136 to 921 1 to 787 exact AAA   787/787
(100 %)
5 diff
(99.4 %id)
BF307924 muscle, rhabdomyosarcoma .h 1 to 731 1 to 722 V5S V6S A8L E9S P10R ...     722/841
(85 %)
15 diff
(98.3 %id)
BF307835 muscle, rhabdomyosarcoma .h 1 to 777 1 to 757 V5S V6S A8L E9S P10R ...     758/921
(82 %)
33 diff
(96.5 %id)
BI115258 muscle, rhabdomyosarcoma .h 1 to 675 1 to 673 V5S V6S A8L E9S P10R ...     673/673
(100 %)
5 diff
(99.3 %id)
BC000417 Muscle, rhabdomyosarcoma .h 2 to 952 1 to 951   tiling clone, available from MGC, AAA   951/951
(100 %)
1 diff
(99.9 %id)
BF219849 muscle, rhabdomyosarcoma .h 21 to 658 1 to 639       639/639
(100 %)
6 diff
(99.1 %id)
AW409606 muscle, rhabdomyosarcoma .h 142 to 588 1 to 447       447/447
(100 %)
8 diff
(98.3 %id)
BF220235 muscle, rhabdomyosarcoma .h 176 to 896 719 to 2       718/756
(94 %)
16 diff
(97.9 %id)
DA946180 Spleen .i 17 to 539 31 to 553 exact tiling clone, capped   552/552
(100 %)
0 diff
(100 %id)
BG764502 melanotic melanoma, high MDR (cell line), skin .j 1 to 753 3 to 749 V43Q A44I D45M Y46S E47L ... tiling clone,   749/749
(100 %)
3 diff
(99.6 %id)
BE409965 choriocarcinoma, placenta .k 1 to 668 1 to 664 D2T G5V K6S L7* tiling clone,   664/664
(100 %)
11 diff
(98.4 %id)
BM793561 Ascites, stomach .l 1 to 409 1 to 409 Q36H Q103R tiling clone,   409/409
(100 %)
2 diff
(99.6 %id)
BF573263 melanotic melanoma, high MDR, skin .m -8 to 370 1 to 379   tiling clone,   379/379
(100 %)
6 diff
(98.5 %id)
CR595676 Neuroblastoma Cot 10-normalized .m 214 to 1635 1 to 1422   tiling clone,   1422/1422
(100 %)
0 diff
(100 %id)
AL521528 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .m 214 to 1075 1 to 862   fully sequenced,   862/862
(100 %)
1 diff
(99.9 %id)
W07812 lung .m 358 to 764 1 to 402       402/402
(100 %)
15 diff
(96.3 %id)
BG167001 hypernephroma, cell line, Kidney .m 911 to 1639 1 to 725   AAA   725/749
(96 %)
15 diff
(98.0 %id)
AA464463 ovarian tumor, ovary .m 929 to 1285 1 to 355   fully sequenced,   355/355
(100 %)
8 diff
(97.8 %id)
CD625543   .m 957 to 1578 630 to 9       622/635
(97 %)
0 diff
(100 %id)
CD625544   .m 964 to 1578 1 to 615       615/625
(98 %)
7 diff
(98.9 %id)
AA011487 liver and spleen .m 981 to 1362 1 to 389   fully sequenced,   389/389
(100 %)
12 diff
(97.0 %id)
BP276997 Kidney .m 1016 to 1588 1 to 572       572/572
(100 %)
3 diff
(99.5 %id)
BQ006602 Chondrosarcoma, Left Pelvis .m 1019 to 1648 648 to 19   AAA   630/630
(100 %)
3 diff
(99.6 %id)
AL521527 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .m 1045 to 1635 588 to 1   fully sequenced,   588/588
(100 %)
4 diff
(99.4 %id)
BU678026 lung .m 1048 to 1653 624 to 19   AAA   606/606
(100 %)
2 diff
(99.7 %id)
BU627128 Bone, Enchondroma cell line .m 1048 to 1663 634 to 19   AAA   616/616
(100 %)
0 diff
(100 %id)
CD370753 Alveolar Macrophage, lung .m 1048 to 1648 619 to 19   AAA   601/601
(100 %)
4 diff
(99.4 %id)
CA412794 Chondrosarcoma Grade II, Left Pelvis .m 1061 to 1646 604 to 19   AAA   586/586
(100 %)
2 diff
(99.7 %id)
BE858784 brain, glioblastoma (pooled) .m 1133 to 1648 516 to 1       516/516
(100 %)
0 diff
(100 %id)
BE222680 brain, oligodendroglioma .m 1135 to 1663 549 to 21   AAA   529/529
(100 %)
0 diff
(100 %id)
AI421211 brain, glioblastoma (pooled) .m 1146 to 1648 503 to 1       503/503
(100 %)
0 diff
(100 %id)
DB570210 hypothalamus .m 1147 to 1662 1 to 516     Submitted on the opposite strand 516/517
(99 %)
2 diff
(99.7 %id)
TI_151737138   .m 1159 to 1648 594 to 105   AAA   490/491
(99 %)
2 diff
(99.6 %id)
AI743335 pooled .m 1171 to 1663 496 to 1       496/496
(100 %)
3 diff
(99.4 %id)
DB571730 hypothalamus .m 1182 to 1651 1 to 470     Submitted on the opposite strand 470/470
(100 %)
2 diff
(99.6 %id)
AW083851 esophagus, squamous cell carcinoma .m 1184 to 1665 482 to 1       482/482
(100 %)
1 diff
(99.8 %id)
DB555384 hypothalamus .m 1187 to 1651 1 to 465     Submitted on the opposite strand 465/465
(100 %)
3 diff
(99.4 %id)
DB536023 hippocampus .m 1190 to 1648 1 to 459     Submitted on the opposite strand 459/460
(99 %)
3 diff
(99.4 %id)
AI421011 Prostate .m 1190 to 1648 478 to 20   AAA   459/459
(100 %)
1 diff
(99.8 %id)
AI436231 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 1190 to 1649 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI472002 pooled .m 1190 to 1649 460 to 1       460/460
(100 %)
1 diff
(99.8 %id)
AI742128 pooled .m 1190 to 1662 473 to 1       473/473
(100 %)
0 diff
(100 %id)
BF002293 colon, colon tumor, RER+ .m 1190 to 1663 474 to 1       474/474
(100 %)
1 diff
(99.8 %id)
DB526333 testis .m 1197 to 1650 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
AV714945   .m 1199 to 1670 1 to 472       472/667
(70 %)
7 diff
(99.0 %id)
AA863374 pooled germ cell tumors .m 1199 to 1648 448 to 1       448/448
(100 %)
7 diff
(98.5 %id)
AI951634 fibrotheoma, ovary .m 1211 to 1669 460 to 2   tiling clone,   459/460
(99 %)
0 diff
(100 %id)
AW613671 2 pooled high-grade transitional celltumors, genitourinary tract .m 1221 to 1650 431 to 2       430/431
(99 %)
0 diff
(100 %id)
BE300685 melanotic melanoma, skin .m 1226 to 1663 453 to 16   AAA   438/438
(100 %)
10 diff
(97.8 %id)
BM665345 eye, Retina Foveal and Macular .m 1229 to 1648 437 to 19   AAA   419/455
(92 %)
6 diff
(98.7 %id)
BM692670 eye, Retina Foveal and Macular .m 1229 to 1648 28 to 446   AAA   419/446
(93 %)
6 diff
(98.7 %id)
BU733976 eye, Retina Foveal and Macular .m 1229 to 1648 437 to 19   AAA   419/455
(92 %)
6 diff
(98.7 %id)
DB554909 hypothalamus .m 1230 to 1662 1 to 431     Submitted on the opposite strand 431/432
(99 %)
3 diff
(99.4 %id)
AI080216 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .m 1239 to 1649 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AA457113 ovarian tumor, ovary .m 1255 to 1663 408 to 1   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
AA989354 breast .m 1256 to 1649 396 to 3       394/396
(99 %)
0 diff
(100 %id)
N79442 lung .m 1260 to 1667 411 to 3       409/411
(99 %)
0 diff
(100 %id)
AI298559 carcinoid, lung .m 1263 to 1665 403 to 1       403/403
(100 %)
1 diff
(99.8 %id)
AA973505 carcinoid, lung .m 1281 to 1649 370 to 2       369/370
(99 %)
0 diff
(100 %id)
AA745871 germinal center B cell .m 1297 to 1650 393 to 40   AAA   354/354
(100 %)
1 diff
(99.8 %id)
AA011488 liver and spleen .m 1332 to 1600 283 to 1   fully sequenced,   283/283
(100 %)
8 diff
(97.2 %id)
AA090582   .m 1346 to 1509 1 to 162       162/171
(94 %)
7 diff
(96.0 %id)
AA953282 2 pooled tumors (clear cell type), Kidney .m 1381 to 1648 268 to 1       268/268
(100 %)
1 diff
(99.7 %id)
BE299412 muscle, rhabdomyosarcoma .n 1 to 588 12 to 599 Q48R tiling clone,   588/607
(96 %)
7 diff
(98.9 %id)
BE294599 muscle, rhabdomyosarcoma .n 20 to 697 1 to 672 Q48R tiling clone,   672/717
(93 %)
9 diff
(98.8 %id)
CN403137 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 152 to 651 1 to 500   tiling clone,   500/500
(100 %)
1 diff
(99.8 %id)
BP381246 adipose tissue .o 1 to 616 8 to 623       623/623
(100 %)
2 diff
(99.7 %id)
AK222473 adipose tissue .o 1 to 950 8 to 957 T70I tiling clone,   957/957
(100 %)
1 diff
(99.9 %id)
BI818858 pooled brain, lung, testis .o 4 to 854 1 to 857       857/858
(99 %)
17 diff
(98.1 %id)
BM459018 melanotic melanoma, skin .o 5 to 944 1 to 951 G206X V211X V213S G214W R215A ...     951/1018
(93 %)
21 diff
(98.0 %id)
BI754222 brain .o 6 to 869 1 to 866   tiling clone,   866/869
(99 %)
9 diff
(99.0 %id)
AI286191 pooled .p 1 to 451 451 to 1 exact tiling clone,   451/451
(100 %)
0 diff
(100 %id)
DB118211 thymus .q 1 to 493 2 to 494 Q69R tiling clone, capped   493/493
(100 %)
1 diff
(99.8 %id)
DA062248 cerebellum .r 17 to 553 37 to 573 exact tiling clone, capped   572/572
(100 %)
0 diff
(100 %id)
BE788268 large cell carcinoma, lung .s 1 to 597 6 to 603 S24Y A25S S26L R27P V28S ... tiling clone,   603/786
(76 %)
11 diff
(98.7 %id)
BE241682 leukopheresis .t -9 to 259 1 to 269 S16P S18X T57A tiling clone,   269/269
(100 %)
6 diff
(97.8 %id)
DA136243 alzheimer cortex .u 1 to 597 2 to 597 exact tiling clone, capped   596/596
(100 %)
1 diff
(99.9 %id)
CB140556 Liver .va -9 to 433 1 to 443 exact     443/443
(100 %)
2 diff
(99.6 %id)
DB178265 kidney, tumor tissue .va 1 to 529 9 to 537 exact tiling clone, capped   536/536
(100 %)
0 diff
(100 %id)
DB486395 hypothalamus .va 17 to 399 41 to 423 P21A     423/423
(100 %)
5 diff
(98.9 %id)
DB500563 hypothalamus .va 17 to 441 41 to 465 P21A     465/465
(100 %)
2 diff
(99.6 %id)
AK001789 ovarian cancer .vb 1 to 2601 7 to 2606 exact tiling clone, available from FLJ,   2606/2606
(100 %)
6 diff
(99.8 %id)
AU133702 ovary, tumor tissue .vb 1 to 647 7 to 654 exact tiling clone, capped   653/658
(99 %)
7 diff
(99.0 %id)
DB274596 uterus .vb 506 to 1065 2 to 561   tiling clone, capped   560/561
(99 %)
1 diff
(99.9 %id)
CN271698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vb 1204 to 1346 1 to 143       143/143
(100 %)
0 diff
(100 %id)
TI_154030189   .vb 1585 to 2586 1077 to 80   AAA   998/1001
(99 %)
26 diff
(97.5 %id)
BX370914 Neuroblastoma Cot 25-normalized .vb 1597 to 2569 974 to 1       974/974
(100 %)
22 diff
(97.8 %id)
CN403138 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vb 1602 to 2264 1 to 663       663/663
(100 %)
0 diff
(100 %id)
T68801 Liver .vb 1609 to 2063 1 to 463       463/465
(99 %)
21 diff
(95.5 %id)
AA716010 pineal gland .vb 1609 to 2035 427 to 2       426/427
(99 %)
0 diff
(100 %id)
TI_149277864   .vb 1612 to 2591 1061 to 103   AAA   959/1012
(94 %)
38 diff
(96.3 %id)
BE544306 cervical carcinoma cell line, cervix .vb 1642 to 2233 1 to 593       593/593
(100 %)
4 diff
(99.4 %id)
CN403140 embryonic stem cells, DMSO-treated H9 cellline .vb 1650 to 2404 7 to 761       755/761
(99 %)
2 diff
(99.8 %id)
AV655802 corresponding non cancerous liver tissue .vb 1707 to 2259 1 to 558     Submitted on the opposite strand 558/647
(86 %)
45 diff
(93.1 %id)
FN147824 breast carcinoma .vb 1807 to 1885 1 to 77       77/77
(100 %)
2 diff
(97.5 %id)
AA455788 ovarian tumor, ovary .vb 1819 to 2251 1 to 430   fully sequenced,   430/430
(100 %)
6 diff
(98.7 %id)
BX105301 ovarian tumor, ovary .vb 1820 to 2492 1 to 672   tiling clone,   672/672
(100 %)
2 diff
(99.8 %id)
BM698978 eye, fetal eyes .vb 1824 to 2414 1 to 591       591/591
(100 %)
0 diff
(100 %id)
CA442413 Fibrosarcoma .vb 1838 to 2586 767 to 19   AAA   749/749
(100 %)
3 diff
(99.6 %id)
AA456610 ovarian tumor, ovary .vb 2221 to 2601 381 to 1   tiling clone, fully sequenced,   381/381
(100 %)
0 diff
(100 %id)
T68735 Liver .vb 2242 to 2587 348 to 1       348/348
(100 %)
6 diff
(98.3 %id)
AU154935 ovary, tumor tissue .vb 2250 to 2601 352 to 1       352/352
(100 %)
1 diff
(99.8 %id)
AA535484 invasive prostate tumor, Prostate .vb 2352 to 2601 1 to 250   AAA   250/250
(100 %)
1 diff
(99.6 %id)
AA629630 ovary .vb 2377 to 2587 219 to 9       211/219
(96 %)
0 diff
(100 %id)
AI865039 lymph node, lymphoma, follicular mixed small and largecell .vb 2387 to 2588 206 to 4       203/206
(98 %)
0 diff
(100 %id)
DA703553   .vc 1 to 445 2 to 446 exact tiling clone, capped   445/449
(99 %)
1 diff
(99.8 %id)
BP213664 cerebrum .vd 1 to 577 2 to 574 E27G V100Q A101I D102M Y103S ... tiling clone,   574/574
(100 %)
3 diff
(99.5 %id)
CN403141 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vd 12 to 716 1 to 708 L73F E74C C75W N76S G77A ... tiling clone,   703/714
(98 %)
8 diff
(98.9 %id)
CN403139 embryonic stem cells, DMSO-treated H9 cellline .vd 431 to 1051 1 to 621   tiling clone,   621/621
(100 %)
0 diff
(100 %id)
BP429769   .vd 460 to 805 1 to 347       347/347
(100 %)
4 diff
(98.9 %id)
CN357958 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vd 501 to 779 1 to 279       279/279
(100 %)
0 diff
(100 %id)
AW242007 pooled .vd 613 to 784 172 to 1       172/172
(100 %)
8 diff
(95.4 %id)
EC565921 Prostate .vd 645 to 761 1 to 115       115/115
(100 %)
5 diff
(95.7 %id)
DB049158 testis .ve 1 to 539 9 to 544   tiling clone, capped   543/543
(100 %)
2 diff
(99.7 %id)
BU155169 melanotic melanoma, skin .ve 7 to 831 12 to 836 L191S G192W I193G C194S D195C ... tiling clone,   825/837
(98 %)
15 diff
(98.3 %id)
DB460933 testis .vf -8 to 464 1 to 476   tiling clone,   476/476
(100 %)
2 diff
(99.6 %id)
BM690879 eye, RPE and Choroid .vf 30 to 728 1 to 701   tiling clone,   701/701
(100 %)
7 diff
(99.1 %id)
DA689980   .vg 1 to 533 9 to 541   tiling clone, capped   540/540
(100 %)
0 diff
(100 %id)
BG036806 adenocarcinoma, cell line, Prostate .vg 64 to 696 12 to 641 G75A K77R E78K V79Y L80S ... tiling clone,   630/998
(63 %)
12 diff
(98.8 %id)
DB247739 uterus .vh 1 to 559 9 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
DA926466 small intestine .vh 17 to 544 43 to 573 E29* capped   572/572
(100 %)
3 diff
(99.5 %id)
CB142314 Liver .vi 1 to 366 9 to 374   tiling clone,   374/375
(99 %)
1 diff
(99.8 %id)
DA155855 amygdala .vi 1 to 559 9 to 567 exact tiling clone, capped   566/566
(100 %)
1 diff
(99.9 %id)
DA509531 brain .vi 17 to 542 37 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA614542   .vj 1 to 554 9 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DB087789 testis .vk 1 to 517 10 to 526 exact tiling clone, capped   525/525
(100 %)
0 diff
(100 %id)
AV685121 hepatocellular carcinoma Gene SMUG1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
F07519 brain, total brain Gene SMUG1, variant not shown         This clone was ignored    
Z40577 brain, total brain Gene SMUG1, variant not shown         This clone was ignored    
DB312879 cord Blood Gene SMUG1, variant not shown         This clone was ignored    
DA419705 cord Blood Gene SMUG1, variant not shown       capped This clone was ignored    
BX643779   Gene SMUG1, variant not shown         This clone was ignored    
CA407948 adipose Gene SMUG1, variant not shown         This clone was ignored    
DB499106 hypothalamus Gene SMUG1, variant not shown         This clone was ignored    
DA628134 Kidney Gene SMUG1, variant not shown       capped Suspected internal deletion, this clone was ignored    
CN403142 embryonic stem cells, DMSO-treated H9 cellline Gene SMUG1, variant not shown         Suspected internal deletion, this clone was ignored    
AK091468 brain Gene SMUG1, variant not shown       available from FLJ, This clone was ignored    
AX747003   Gene SMUG1, variant not shown         This clone was ignored    
DB315779 brain Gene SMUG1, variant not shown         This clone was ignored    
DA499028 brain Gene SMUG1, variant not shown       capped This clone was ignored    
AW410642 muscle, rhabdomyosarcoma Gene SMUG1, variant not shown         This clone was ignored    
BG706339 brain, hypothalamus Gene SMUG1, variant not shown         This clone was ignored    
BG707005 brain, hypothalamus Gene SMUG1, variant not shown         This clone was ignored    
BI596697 brain, hypothalamus Gene SMUG1, variant not shown         This clone was ignored    
BI597302 brain, hypothalamus Gene SMUG1, variant not shown         This clone was ignored    
BU599444 mixed (pool of 40 RNAs) Gene SMUG1, variant not shown         This clone was ignored    
TI_45209125   Gene SMUG1, variant not shown         This clone was ignored    
TI_45215273   Gene SMUG1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi, .vj, .vk Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI